Shoklo Malaria Research Unit, Mae Sot, Thailand.
BMC Infect Dis. 2011 Apr 27;11:108. doi: 10.1186/1471-2334-11-108.
Detection of Streptococcus pneumoniae C-polysaccharide in urine is a useful rapid diagnostic test for pneumococcal infections in adults. In young children, high rates of false positive results have been documented due to detection of concurrent nasopharyngeal pneumococcal carriage. The relationship between pneumococcal carriage and urinary antigen detection in adults from developing countries with high pneumococcal carriage prevalence has not been well established.
We nested an evaluation of the BinaxNOW S. pneumoniae test within a longitudinal mother-infant pneumococcal carriage study in Karen refugees on the Thailand-Myanmar border. Paired urine and nasopharyngeal swab specimens were collected from 98 asymptomatic women at a routine study follow-up visit. The urine specimens were analyzed with the BinaxNOW test and the nasopharyngeal swabs were semi-quantitatively cultured to identify pneumococcal colonization.
24/98 (25%) women were colonized by S. pneumoniae but only three (3%) had a positive BinaxNOW urine test. The sensitivity of the BinaxNOW test for detection of pneumococcal colonization was 4.2% (95% CI: 0.1-21.1%) with a specificity of 97.3% (95% CI: 90.6-99.7%). Pneumococcal colonization was not associated with having a positive BinaxNOW test (odds ratio 1.6; 95% CI: 0.0-12.7; p=0.7).
Significant numbers of false positive results are unlikely to be encountered when using the BinaxNOW test to diagnose pneumococcal infection in adults from countries with moderate to high rates of pneumococcal colonization.
检测尿中肺炎链球菌 C 多糖是一种用于诊断成人肺炎链球菌感染的有用的快速诊断试验。在幼儿中,由于同时检测到鼻咽部肺炎链球菌携带,已记录到较高的假阳性率。在高肺炎链球菌携带率的发展中国家,肺炎链球菌携带与尿液抗原检测之间的关系尚未得到很好的确定。
我们在泰国-缅甸边境的 Karen 难民中进行了一项纵向母婴肺炎链球菌携带研究,在该研究中嵌套评估了 BinaxNOW S. pneumoniae 试验。在常规研究随访就诊时,从 98 名无症状女性中采集配对的尿液和鼻咽拭子标本。使用 BinaxNOW 试验分析尿液标本,并对鼻咽拭子进行半定量培养以确定肺炎链球菌定植。
98 名女性中有 24 名(25%)被肺炎链球菌定植,但仅有 3 名(3%)的 BinaxNOW 尿液检测呈阳性。BinaxNOW 检测对肺炎链球菌定植的敏感性为 4.2%(95%CI:0.1-21.1%),特异性为 97.3%(95%CI:90.6-99.7%)。肺炎链球菌定植与 BinaxNOW 检测阳性无关(比值比 1.6;95%CI:0.0-12.7;p=0.7)。
在高或中度肺炎链球菌携带率的国家中,使用 BinaxNOW 试验诊断成人肺炎链球菌感染时,不太可能遇到大量假阳性结果。